Keyphrases
5-CT
8%
99mTc-sestamibi
8%
Adenosine Receptor Agonists
8%
Blood-brain Barrier
100%
Blood-brain Barrier Permeability
8%
Brain Imaging
8%
Brain Tumor
8%
Cardiac Evaluation
8%
Cardiac Testing
16%
Clinically Indicated
8%
CNS Malignancies
8%
Computational Imaging
16%
Contrast Agent
8%
CT Hounsfield Units
8%
Document Changes
8%
Dosing Schedule
8%
Drug Entry
8%
FDA-approved Drugs
16%
High Concentration
8%
Hounsfield Units
8%
Imaging Agents
25%
Intracranial Disease
8%
No Significant Difference
8%
Patient Care
8%
Pharmacologic
16%
Radioactive Counts
8%
Radionuclides
8%
Regadenoson
100%
Rodents
8%
Single-photon Emission Computed Tomography (SPECT)
16%
SPECT Imaging
8%
SPECT-CT
8%
T-test
8%
Temozolomide
8%
Visipaque
8%
Nursing and Health Professions
Adenosine Receptor Stimulating Agent
8%
Animal Experiment
8%
Blood-Brain Barrier
100%
Contrast Medium
8%
Dextran
8%
Disease
8%
Exercise Test
8%
Food and Drug Administration
16%
Heart Stress
16%
Imaging
41%
Intracranial Tumor
8%
Iodixanol
8%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
8%
Pilot Study
100%
Radioisotope
8%
Regadenoson
100%
Single-Photon Emission Computed Tomography
33%
Student T Test
8%
Temozolomide
8%
Medicine and Dentistry
Adenosine Receptor Agonist
8%
Blood Brain Barrier
100%
Brain Imaging
8%
Cancer
8%
Cardiac Stress Test
8%
Contrast Medium
8%
Dextran
8%
Disease
8%
Heart Stress
8%
Imaging Agent
25%
Intracranial Tumor
8%
Iodixanol
8%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
8%
Radioisotope
8%
Regadenoson
100%
Single-Photon Emission Computed Tomography
33%
Student T Test
8%
Temozolomide
8%
Neuroscience
Adenosine Receptor
8%
Blood Brain Barrier
100%
Brain Imaging
8%
Contrast Medium
8%
Dextran
8%
Intracranial Tumor
8%
Receptor Agonists
8%
Regadenoson
100%
Single-Photon Emission Computed Tomography
33%
Technetium-99m
8%
Temozolomide
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Receptor Stimulating Agent
8%
Blood-Brain Barrier
100%
Contrast Medium
8%
Dextran
8%
Disease
8%
Heart Stress
16%
Intracranial Tumor
8%
Iodixanol
8%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
8%
Radioisotope
8%
Regadenoson
100%
Temozolomide
8%